中国防痨杂志 ›› 2026, Vol. 48 ›› Issue (7): 1051-1063.doi: 10.19982/j.issn.1000-6621.20260030
收稿日期:2026-01-16
出版日期:2026-07-10
发布日期:2026-07-02
通信作者:
李风森,Email:基金资助:
Yin Shiliu1, Xu Dan2, Li Zheng2, Wang Yanqian3, Li Fengsen3(
)
Received:2026-01-16
Online:2026-07-10
Published:2026-07-02
Contact:
Li Fengsen, Email: Supported by:摘要:
目的: 运用文献计量学方法分析结核后遗症领域的研究特征、热点主题与知识脉络,为该领域的后续深入探索提供参考。方法: 基于Web of Science核心合集数据库,检索时间范围为2006年1月1日至2025年12月1日,检索与结核后遗症相关的“article”和“review”,利用CiteSpace V6.4.R1、VOSviewer 1.6.18软件对发文特征、国家、机构、作者、期刊分布、合作网络、文献共被引,以及关键词聚类、共现、突现及时间线进行分析。结果: 2006—2025年结核后遗症研究的发文量由2006年的2篇增至2025年的42篇。发文涉及45个国家/地区和44种期刊,发文量居于前5名的国家是美国(74篇)、英国(55篇)、南非(48篇)、中国(36篇)、韩国(23篇)。高产机构前3位为开普敦大学(10篇)、斯泰伦博斯大学(9篇)及威特沃特斯兰德大学(7篇)。关键词分析显示,共纳入333个关键词,生成671条连线,网络密度为0.012。聚类图显示,Q=0.6656、S=0.8486,依次为气流受限、肺康复、抗逆转录病毒治疗、肺功能损害、慢性肺曲霉病、结核后肺疾病、慢性阻塞性肺疾病、危险因素、肺肿瘤、肺纤维化。研究热点集中于结核后肺疾病、肺功能损伤、结核后遗症流行病学特征、危险因素及社会负担,其中结核后肺疾病的突现强度始终处于较高水平。结论: 结核后遗症当前研究聚焦气流受限、结核后肺疾病、肺功能损伤等核心议题,虽有肺康复相关干预探索,但缺乏精准化方案与共识指南。未来应聚焦发病机制、精准干预与康复管理核心方向,加大研究投入与探索力度,完善多学科协作体系,以全面提升结核后遗症的防治质量与患者长期健康水平。
中图分类号:
尹石榴, 徐丹, 李争, 王岩倩, 李风森. 结核后遗症研究的文献计量学分析(2006—2025年):一项基于Web of Science的初步探索[J]. 中国防痨杂志, 2026, 48(7): 1051-1063. doi: 10.19982/j.issn.1000-6621.20260030
Yin Shiliu, Xu Dan, Li Zheng, Wang Yanqian, Li Fengsen. Bibliometric analysis of research on post-tuberculosis sequelae (2006—2025): a preliminary exploration based on Web of Science[J]. Chinese Journal of Antituberculosis, 2026, 48(7): 1051-1063. doi: 10.19982/j.issn.1000-6621.20260030
表4
结核后遗症研究领域被引频次最高的前10篇文献
| 第一作者 | 标题 | 发表期刊 | 发表年份 | 总被引频次 |
|---|---|---|---|---|
| Ravimohan[ | Tuberculosis and lung damage: f-rom epidemiology to pathophysi-ology | European Respiratory Review | 2018 | 344 |
| Romanoski[ | Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis | Lancet Global Health | 2019 | 202 |
| Allwood[ | Post-tuberculosis lung health: perspectives from the First Internatonal Symposium | International Journal of Tuberculosis and Lung Disease | 2020 | 154 |
| Allwood[ | Post-Tuberculosis Lu-ng Disease: Clinical Review of an Under-Recognised Global Challenge | Respiration | 2021 | 151 |
| Menzies[ | Lifetime burden of disease due t-o incident tuberculosis: a global reappraisal including post-tuberculosis sequelae | Lancet Global Health | 2021 | 149 |
| Meghji[ | Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study | Thorax | 2021 | 128 |
| Migliori[ | Clinical standards f-or the assessment, management and rehabilitation of post-TB lung disease | International Journal of Tuberculosis and Lung Disease | 2021 | 127 |
| Dodd[ | Quantifying the global number of tuberculosis survivors: a modelling study | The Lancet Infectious Diseases | 2021 | 100 |
| Van Kampen[ | International research and guidelines on post-tuberculosis chronic lung disorders: a systematic sco-ping review | BMJ Global Health | 2018 | 92 |
| Nightingale[ | Post-TB health and wellbeing | International Journal of Tuberculosis and Lung Disease | 2023 | 79 |
| [1] | 屈燕, 李涛, 马文斌, 等. 世界卫生组织《2025年全球结核病报告》解读[J]. 结核与肺部疾病杂志, 2025, 6(6): 613-623. doi:10.19983/j.issn.2096-8493.20250178. |
| [2] |
Allwood B W, van der Zalm M M, Amaral A F S, et al. Post-tuberculosis lung health: perspectives from the First International Symposium[J]. Int J Tuberc Lung Dis, 2020, 24(8): 820-828. doi:10.5588/ijtld.20.0067.
pmid: 32912387 |
| [3] |
Allwood B W, Nightingale R, Agbota G, et al. Perspectives from the 2nd International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes[J]. IJTLD Open, 2024, 1(3): 111-123. doi:10.5588/ijtldopen.23.0619.
pmid: 38966406 |
| [4] | Ravimohan S, Kornfeld H, Weissman D, et al. Tuberculosis and lung damage: from epidemiology to pathophysiology[J]. Eur Respir Rev, 2018, 27(147): 170077. doi:10.1183/16000617.0077-2017. |
| [5] |
Meghji J, Lesosky M, Joekes E, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study[J]. Thorax, 2020, 75(3): 269-278. doi:10.1136/thoraxjnl-2019-213808.
pmid: 32102951 |
| [6] | Xing Z, Sun T, Janssens J P, et al. Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey[J]. Thorax, 2023, 78(3): 274-280. doi:10.1136/thoraxjnl-2021-218345. |
| [7] | Woldesemayat E M, Vera J H, Tanner C, et al. Lung function of tuberculosis patients after completion of treatment in Sidama, South Ethiopia[J]. Front Med (Lausanne), 2025, 12: 1451861. doi:10.3389/fmed.2025.1451861. |
| [8] | Basham C A, Karim M E, Cook V J, et al. Post-tuberculosis airway disease: A population-based cohort study of people immigrating to British Columbia, Canada, 1985—2015[J]. EClinicalMedicine, 2021, 33: 100752. doi:10.1016/j.eclinm.2021.100752. |
| [9] |
Chin A T, Rylance J, Makumbirofa S, et al. Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study[J]. Int J Tuberc Lung Dis, 2019, 23(2): 203-211. doi:10.5588/ijtld.18.0313.
pmid: 30808453 |
| [10] | Gai X, Allwood B, Sun Y. Post-tuberculosis lung disease and chronic obstructive pulmonary disease[J]. Chin Med J (Engl), 2023, 136(16): 1923-1928. doi:10.1097/CM9.0000000000002771. |
| [11] | Joo D H, Kim M C, Sin S, et al. Incidence and Risk Factors of Tuberculosis-Associated Chronic Obstructive Pulmonary Disease[J]. Int J Chron Obstruct Pulmon Dis, 2025, 20: 2091-2102. doi:10.2147/COPD.S523732. |
| [12] | Choi H, Lee H, Ra S W, et al. Clinical Characteristics of Patients with Post-Tuberculosis Bronchiectasis: Findings from the KMBARC Registry[J]. J Clin Med, 2021, 10(19): 4542. doi:10.3390/jcm10194542. |
| [13] | Raj P A, Leach L A D, Davis C E. Chronic Lung Damage After Tuberculosis: A Focus on Bronchiectasis and Its Management[J]. Am J Respir Crit Care Med, 2025, 211: A2049. doi:10.1164/ajrccm.2025.211.Abstracts.A2409. |
| [14] |
Liu T, Gao L, Xie S, et al. Clinical and imaging spectrum of tuberculosis-associated fibrosing mediastinitis[J]. Clin Respir J, 2018, 12(5): 1974-1980. doi:10.1111/crj.12766.
pmid: 29356415 |
| [15] | Louw E H, van Heerden J A, Kalla I S, et al. Scoping review of post-TB pulmonary vascular disease: Proceedings from the 2nd International Post-Tuberculosis Symposium[J]. Pulm Circ, 2024, 14(3): e12424. doi:10.1002/pul2.12424. |
| [16] | Louw E, Baines N, Maarman G, et al. The prevalence of pulmonary hypertension after successful tuberculosis treatment in a community sample of adult patients[J]. Pulm Circ, 2023, 13(1): e12184. doi:10.1002/pul2.12184. |
| [17] | Hanalla M, Mohamed M A, Virnig S, et al. Post-tuberculosis Destroyed Lung Syndrome: A Case Report and Review of Management Challenges[J]. Am J Respir Crit Care Med, 2025, 211: A2376. doi:10.1164/ajrccm.2025.211.Abstracts.A2376. |
| [18] | Wu C Y, Hu H Y, Pu C Y, et al. Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study[J]. Cancer, 2011, 117(3): 618-24. doi:10.1002/cncr.25616. |
| [19] |
Simonsen D F, Farkas D K, Søgaard M, et al. Tuberculosis and risk of cancer: a Danish nationwide cohort study[J]. Int J Tuberc Lung Dis, 2014, 18(10): 1211-1219. doi:10.5588/ijtld.14.0161.
pmid: 25216835 |
| [20] | Wu M, Yang Y N, Wang F, et al. Development of a Predictive Risk Model for Recurrence of Chronic Pulmonary Aspergillosis in Post-Tuberculosis Patients: A Retrospective Observational Study[J]. Int J Gen Med, 2025, 18: 7243-7254. doi:10.2147/IJGM.S544265. |
| [21] | Soundappan K, Singh Sehgal I, Prabhakar N, et al. Incidence and prevalence of chronic pulmonary aspergillosis in patients with post-tuberculosis lung abnormality: Results from a community survey in North India[J]. Mycoses, 2024, 67(3): e13711. doi:10.1111/myc.13711. |
| [22] | Rozaliyani A, Setianingrum F, Isbaniah F, et al. A Silent Threat in Post-Tuberculosis Patients: Chronic Pulmonary Aspergillosis Survey in Multiple Regions of Indonesia (I-CHROME Study)[J]. J Fungi (Basel), 2025, 11(5): 329. doi:10.3390/jof11050329. |
| [23] | Purwono A, Fachrucha F, Agustin H, et al. Chronic Pulmonary Aspergillosis in Patient With Post-Tuberculosis Treatment and Recurrent Hemoptysis[J]. Am J Respir Crit Care Med, 2023, 207: A5571. |
| [24] | Yang J, Kim S H, Sim J K, et al. Tuberculosis survivors and the risk of cardiovascular disease: analysis using a nationwide survey in Korea[J]. Front Cardiovasc Med, 2024, 11: 1364337. doi:10.3389/fcvm.2024.1364337. |
| [25] | Mendoza-Torres J, Durán-Hernández N, Choreño-Parra J, et al. Hippocampal syndrome secondary to tuberculosis: From neuroinflammation to neurodegeneration[J]. Tuberculosis (Edinb), 2025, 153: 102653. doi:10.1016/j.tube.2025.102653. |
| [26] | Lo H Y, Suo J, Chang H J, et al. Risk factors associated with death in a 12-month cohort analysis of tuberculosis patients: 12-month follow-up after registration[J]. Asia Pac J Public Health, 2015, 27(2): NP758-68. doi:10.1177/1010539511429591. |
| [27] | Kim S, Pelissari D M, Harada L O, et al. Long-term Mortality Trends Among Individuals With Tuberculosis: A Retrospective Cohort Study of Individuals Diagnosed With Tuberculosis in Brazil[J]. Clin Infect Dis, 2026, 82(1): e1-e8. doi:10.1093/cid/ciaf206. |
| [28] | 秦丽莉, 杨澄清, 麦洪珍, 等. 结核后肺曲霉病的临床诊疗研究进展[J]. 中国防痨杂志, 2025, 47(4): 498-504. doi:10.19982/j.issn.1000-6621.20240527. |
| [29] | 宋菲尔, 毛燕君, 夏秋月, 等. 结核后肺疾病患者患病率和影响因素的Meta分析[J]. 中国防痨杂志, 2025, 47(3): 322-330. doi:10.19982/j.issn.1000-6621.20240454. |
| [30] |
Romanowski K, Baumann B, Basham C A, et al. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2019, 19(10): 1129-1137. doi:10.1016/S1473-3099(19)30309-3.
pmid: 31324519 |
| [31] | Allwood BW, Byrne A, Meghji J, et al. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge[J]. Respiration, 2021, 100(8): 751-763. doi:10.1159/000512531. |
| [32] |
Menzies N A, Quaife M, Allwood B W, et al. Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae[J]. Lancet Glob Health, 2021, 9(12): e1679-e1687. doi:10.1016/S2214-109X(21)00367-3.
pmid: 34798027 |
| [33] |
Migliori G B, Marx F M, Ambrosino N, et al. Clinical standards for the assessment, management and rehabilitation of post-TB lung disease[J]. Int J Tuberc Lung Dis, 2021, 25(10): 797-813. doi:10.5588/ijtld.21.0425.
pmid: 34615577 |
| [34] |
Dodd P J, Yuen C M, Jayasooriya S M, et al. Quantifying the global number of tuberculosis survivors: a modelling study[J]. Lancet Infect Dis, 2021, 21(7): 984-992. doi:10.1016/S1473-3099(20)30919-1.
pmid: 33640076 |
| [35] | van Kampen S C, Wanner A, Edwards M, et al. International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review[J]. BMJ Glob Health, 2018, 3(4): e000745. doi:10.1136/bmjgh-2018-000745. |
| [36] |
Nightingale R, Carlin F, Meghji J, et al. Post-TB health and wellbeing[J]. Int J Tuberc Lung Dis, 2023, 27(4): 248-283. doi:10.5588/ijtld.22.0514.
pmid: 37035971 |
| [37] |
Mpagama S G, Msaji K S, Kaswaga O, et al. The burden and determinants of post-TB lung disease[J]. Int J Tuberc Lung Dis, 2021, 25(10): 846-853. doi:10.5588/ijtld.21.0278.
pmid: 34615582 |
| [38] |
Thomson H, Baines N, Huisamen T, et al. A new understanding of clinical patterns in post-TB lung disease[J]. Int J Tuberc Lung Dis, 2024, 28(3): 115-121. doi:10.5588/ijtld.23.0327.
pmid: 38454184 |
| [39] | Webber T, Macdonald C, Tameris M, et al. Immune, metabolic, anatomical, and functional features of people after successful tuberculosis treatment: an exploratory analysis[J]. Sci Rep, 2025, 15(1): 18392. doi:10.1038/s41598-025-01656-1. |
| [40] | Wang L L, Lu H W, Li L L, et al. Destroyed lung contributes to the recurrence of hemoptysis after bronchial artery embolization in patients with post-tuberculosis bronchiectasis[J]. J Infect Public Health, 2024, 17(7): 102446. doi:10.1016/j.jiph.2024.05.003. |
| [41] | Auld S C, Barczak A K, Bishai W, et al. Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the Second International Post-Tuberculosis Symposium[J]. Am J Respir Crit Care Med, 2024, 210(8): 979-993. doi:10.1164/rccm.202402-0374SO. |
| [42] | Santos A P, Rodrigues L S, Rother N, et al. The role of neutrophil response in lung damage and post-tuberculosis lung disease: a translational narrative review[J]. Front Immunol, 2025, 16: 1528074. doi:10.3389/fimmu.2025.1528074. |
| [1] | 刘嘉, 谭晶, 田瑶, 傅满姣, 刘辉敏, 陈红梅, 翟安, 康怡, 陈亮, 贝承丽. 入住重症监护室的HIV阴性播散性结核病患者预后不良危险因素分析及预测模型构建[J]. 中国防痨杂志, 2026, 48(7): 933-940. |
| [2] | 周文仙, 秦娅梅, 杨璇, 赵娜, 武昆利, 贺启莲. 结核后肺疾病患者症状群体验及管理需求的质性研究[J]. 中国防痨杂志, 2026, 48(7): 1015-1020. |
| [3] | 叶觉鲜, 周乾坤, 李冬兰, 覃雄之, 樊爱敏, 刘爱梅. 基于德尔菲法和层次分析法的抗结核药物临床综合评价体系构建[J]. 中国防痨杂志, 2026, 48(7): 948-957. |
| [4] | 高娴, 尚希钰, 刘甜甜, 杨洁, 李子煕, 孙燕歌, 韦锦生, 成诗明, 马艳, 李洪智. 散结贴外治破溃期淋巴结结核的态靶辨治思路[J]. 中国防痨杂志, 2026, 48(7): 1021-1029. |
| [5] | 李继科, 罗槑, 邹莉萍, 叶庆, 罗祥一, 龚蒙萌, 张慧芳, 曹玉清, 傅小燕, 冯霞, 周小龙, 杨映梅, 庞文箫, 马艳, 吴桂辉. 中药内服外用辅助治疗腹腔结核合并肠梗阻的临床研究[J]. 中国防痨杂志, 2026, 48(7): 1030-1037. |
| [6] | 中国防痨协会, 中国防痨协会营养专业分会, 湖南省防痨协会, 湖南省结核病防治所(湖南省胸科医院), 上海市肺科医院, 中南大学湘雅公共卫生学院. 结核病与糖尿病共病营养治疗专家共识[J]. 中国防痨杂志, 2026, 48(7): 913-924. |
| [7] | 陈依娜, 李卫丹, 朱凯强, 唐慧玲. Serfling回归模型在浙江省金华市结核病流行特征解析中的应用研究[J]. 中国防痨杂志, 2026, 48(7): 941-947. |
| [8] | 刘良丽, 杨云斌, 杨蕊, 陈金瓯, 杨星, 邱玉冰, 李玲, 许琳. 利福平耐药肺结核患者不良治疗结局时间变化特征及影响因素分析:基于不同治疗方案的比较[J]. 中国防痨杂志, 2026, 48(7): 958-964. |
| [9] | 赵丽萍, 宗星煜, 曹玉清, 姜慧, 蔡秋杰, 马艳, 穆婷婷, 刘晓明, 刘斌, 梁博文, 曹艳华, 李波, 罗敬月, 王桂荣, 黄麦玲. 中和汤辅助治疗气血两虚证脓肿型淋巴结结核的随机对照研究短期疗效观察[J]. 中国防痨杂志, 2026, 48(7): 1044-1050. |
| [10] | 魏潇雯, 董宁, 吴元浩, 杨洁, 杨依静, 沈克兰, 张林. 基于达标理论的出院准备服务在肺结核患者中的应用研究[J]. 中国防痨杂志, 2026, 48(7): 1007-1014. |
| [11] | 高跃华, 周波, 李吉, 卢芳, 冯加义. 多学科协助护理腹腔结核合并高流量瘘伴重度营养不良患儿一例[J]. 中国防痨杂志, 2026, 48(7): 1069-1072. |
| [12] | 周兰彩, 芦永赞, 荣宁宁, 杨汝燕, 王青, 孟秋月, 郝荣荣, 宁海川, 高杨. 多学科协作护理模式下的全病程护理管理妊娠晚期肺结核患者一例[J]. 中国防痨杂志, 2026, 48(7): 1073-1076. |
| [13] | 曾谊, 高卫卫, 时翠林, 苏世芳, 王华, 唐军, 施伎婵, 聂琦, 孙艳, 崔俊伟, 杨均均, 范佳画. 愈结力对初治活动性肺结核伴营养不良患者营养支持治疗的有效性和安全性:一项随机对照多中心临床研究[J]. 中国防痨杂志, 2026, 48(7): 925-932. |
| [14] | 矫晓克, 董可鑫, 杨新亮, 聂文娟. 含贝达喹啉方案治疗利福平耐药结核病患者QTc间期>500ms的危险因素分析[J]. 中国防痨杂志, 2026, 48(7): 992-999. |
| [15] | 刘爱梅, 刘桑, 冯丽珍, 王晴. 基于CD4+ T淋巴细胞水平的结核病并发HIV/AIDS手术效果评价[J]. 中国防痨杂志, 2026, 48(7): 1000-1006. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可